371 related articles for article (PubMed ID: 25027463)
1. [Topiramate in substance-related and addictive disorders].
Cohen J; Dervaux A; Laqueille X
Presse Med; 2014 Sep; 43(9):892-901. PubMed ID: 25027463
[TBL] [Abstract][Full Text] [Related]
2. Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features.
Nourredine M; Jurek L; Angerville B; Longuet Y; de Ternay J; Derveaux A; Rolland B
CNS Drugs; 2021 Feb; 35(2):177-213. PubMed ID: 33591567
[TBL] [Abstract][Full Text] [Related]
3. Topiramate in the treatment of substance-related disorders: a critical review of the literature.
Shinn AK; Greenfield SF
J Clin Psychiatry; 2010 May; 71(5):634-48. PubMed ID: 20361908
[TBL] [Abstract][Full Text] [Related]
4. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
Dalai SS; Adler S; Najarian T; Safer DL
Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
[TBL] [Abstract][Full Text] [Related]
5. Treatment of binge-eating disorder with topiramate: a clinical case series.
Shapira NA; Goldsmith TD; McElroy SL
J Clin Psychiatry; 2000 May; 61(5):368-72. PubMed ID: 10847312
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
[TBL] [Abstract][Full Text] [Related]
9. Topiramate for binge-eating disorder associated with obesity.
Tata AL; Kockler DR
Ann Pharmacother; 2006 Nov; 40(11):1993-7. PubMed ID: 17047134
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.
Arbaizar B; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2008; 30(5):471-5. PubMed ID: 18774432
[TBL] [Abstract][Full Text] [Related]
11. Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial.
Reis AD; Castro LA; Faria R; Laranjeira R
Braz J Psychiatry; 2008 Jun; 30(2):132-5. PubMed ID: 18470406
[TBL] [Abstract][Full Text] [Related]
12. Clinical uses of naltrexone: a review of the evidence.
Modesto-Lowe V; Van Kirk J
Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
[TBL] [Abstract][Full Text] [Related]
13. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
[TBL] [Abstract][Full Text] [Related]
14. The potential interest of topiramate in addiction.
Thorens G; Billieux J; Manghi R; Khan R; Khazaal Y; Zullino DF
Curr Pharm Des; 2011; 17(14):1410-5. PubMed ID: 21524260
[TBL] [Abstract][Full Text] [Related]
15. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.
McElroy SL; Hudson JI; Capece JA; Beyers K; Fisher AC; Rosenthal NR;
Biol Psychiatry; 2007 May; 61(9):1039-48. PubMed ID: 17258690
[TBL] [Abstract][Full Text] [Related]
16. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
[TBL] [Abstract][Full Text] [Related]
17. Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
Brownley KA; Berkman ND; Peat CM; Lohr KN; Cullen KE; Bann CM; Bulik CM
Ann Intern Med; 2016 Sep; 165(6):409-20. PubMed ID: 27367316
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial.
García Campayo J; Sobradiel N; Alda M; Mas A; Andrés E; Magallón R; Crucelaegui A; Sanz B
BMC Fam Pract; 2008 May; 9():28. PubMed ID: 18462502
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based pharmacological treatment of substance use disorders and pathological gambling.
van den Brink W
Curr Drug Abuse Rev; 2012 Mar; 5(1):3-31. PubMed ID: 22126708
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of N-acetylcysteine in the treatment of addictions.
Asevedo E; Mendes AC; Berk M; Brietzke E
Braz J Psychiatry; 2014; 36(2):168-75. PubMed ID: 24676047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
